NDC 62332-184-03 - Telmisartan and Amlodipine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62332-184
- Requested NDC
- 62332-184-03
- Package NDCs from labels
- 62332-184-03, 62332-184-10, 62332-184-30
- Manufacturer
- Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited
- Effective date
- 2026-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TELMISARTAN - Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 2026-10-23 | Human Prescription Drug Label |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Telmisartan | TELMISARTAN | AvKARE | 71902893-55da-4286-8b25-b528641489ef | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 6e038d92-09f3-4517-947e-146d007114b8 | 2026-01-14 | Warnings, Adverse reactions | 864V2Q084H |
| Telmisartan | TELMISARTAN | Solco Healthcare US, LLC | 77442f0b-b522-4b19-ac1f-f0ce8576f0be | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | AvKARE | 1b30c3fe-5c84-0d42-e063-6394a90a81d8 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | AvKARE | feb9438a-9cbc-4855-e053-6394a90af15e | 2026-01-13 | Warnings, Adverse reactions | 864V2Q084H |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Lupin Pharmaceuticals, Inc. | b88054b3-fafa-4b4e-acf5-5294e5555720 | 2026-01-09 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 47e494d2-8971-3f8f-e063-6394a90adb20 | 2026-01-08 | Warnings, Adverse reactions | 864V2Q084H |
| Large Intestine Formula 2103 | LARGE INTESTINE FORMULA | Professional Complementary Health Formulas | 532eb4c6-0f3f-4853-89e2-43168e118d65 | 2026-01-08 | Warnings | XM0M87F357 |
| Geopathic Stress Drops 2096 | GEOPATHIC STRESS DROPS | Professional Complementary Health Formulas | 7d7302b8-3959-4e1e-ad1f-88d265ba9d32 | 2026-01-08 | Warnings | XM0M87F357 |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | e01efe66-2f31-4261-92ca-0b41f27104da | 2026-01-07 | Warnings, Adverse reactions | 864V2Q084H |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Glenmark Pharmaceuticals Inc., USA | 1e55800d-f77c-4950-a6d7-2055f4c7ea17 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Olmesartan medoxomil, amlodipine and hydrochlorothiazide | OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | 45e975ff-07b1-411a-96ee-a011d1619b1e | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE and OLMESARTAN medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Macleods Pharmaceuticals Limited | c86a3c45-c906-46c9-9f7b-6c3d89bbe48f | 2026-01-03 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Northwind Health Company, LLC | fa153720-b24c-60d0-e053-6294a90a97d5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Northwind Health Company, LLC | f2b56630-4e3a-6f9c-e053-2a95a90a4650 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | f2b8274b-d849-6793-e053-2a95a90aa0e8 | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | f32bb322-68d7-a4ca-e053-2995a90aa7b0 | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 0c5784b9-5542-144f-e063-6394a90a7ebc | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 03fe9ad2-3a1a-78db-e063-6294a90a2ed3 | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| Telmisartan | TELMISARTAN | A-S Medication Solutions | eaed12cd-5bfe-4c98-9afc-025ed86a294f | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.